Ipamorelin 5mg Peptides
Built for precision-driven workflows, this ipamorelin vial is manufactured to deliver consistent results in serious research settings.
This product is a lyophilized peptide vial featuring ipamorelin at a total strength of 5mg. Style: lyophilized powder for controlled laboratory handling. Active ingredient type: a growth hormone secretagogue peptide selected for targeted pathway investigation and method development where uniformity and clarity of composition are essential.
- Each vial contains 5mg of Ipamorelin, a selective GHSR agonist suited for exploring pulsatile growth hormone signaling, receptor selectivity, and downstream pathway characterization in controlled research models.
As a non-edible laboratory material, this lyophilized format supports dependable reconstitution and protocol-driven use. The stable peptide cake is designed for clear dissolution in appropriate laboratory solvents, aiding accurate aliquoting and reproducible preparation. Researchers value this format for in vitro assays, analytical method validation, receptor-binding evaluations, and other preclinical investigations that demand consistent peptide integrity across runs and between lots.
Peptide Scientific Labs prioritizes quality at every step. Ipamorelin is produced and packaged in the USA under rigorous controls, with identity and purity assessed by analytical methods such as HPLC and mass spectrometry. Lots are screened to help ensure low residual solvents and minimal process-related impurities, and vials are handled with sterile technique to protect material integrity. Each unit ships with clear lot identification to support traceability and documentation, and packaging is designed with protective measures to maintain product condition from our facility to your laboratory.
Quality and compliance you can trust: premium-grade raw materials, controlled synthesis and lyophilization, meticulous in-process checks, and post-production testing to verify consistency. Our standards reflect a research-first mindset—clean, credible, and exacting—so your team can focus on generating reliable data.
For laboratory research only. Not for human or animal consumption, injection, or clinical use. Handle using appropriate laboratory safety procedures and dispose of according to your institution’s guidelines.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is Ipamorelin?
Ipamorelin is a growth-hormone secretagogue that acts primarily through the ghrelin receptor pathway. It is often described as more selective than older secretagogues because it is studied for GH release with less interest in off-target hormone stimulation. For product copy, it should be described as a research peptide for endocrine signaling studies.
What is Ipamorelin typically studied for?
Ipamorelin is typically studied for endogenous growth-hormone release, GH/IGF-1-axis signaling, recovery-related models, and pulse-based endocrine research. It is commonly paired with GHRH analogs in blend products because those two signaling routes are often examined together.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
This Product Contains
